Agenus
AGEN
#8939
Rank
โ‚น12.40 B
Marketcap
โ‚น364.80
Share price
-2.64%
Change (1 day)
25.56%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2025 (TTM): โ‚น9.24 Billion

According to Agenus 's latest financial reports the company's current revenue (TTM ) is โ‚น9.59 Billion. In 2024 the company made a revenue of โ‚น8.87 Billion a decrease over the revenue in the year 2023 that were of โ‚น13.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น9.24 B4.19%
2024 โ‚น8.87 B-31.79%
2023 โ‚น13.01 B60.42%
2022 โ‚น8.11 B-63.14%
2021 โ‚น22.00 B241.29%
2020 โ‚น6.44 B-39.74%
2019 โ‚น10.69 B316.02%
2018 โ‚น2.57 B-6.05%
2017 โ‚น2.73 B78.47%
2016 โ‚น1.53 B-6.99%
2015 โ‚น1.64 B272.94%
2014 โ‚น0.44 B135.06%
2013 โ‚น0.18 B-78.47%
2012 โ‚น0.87 B499.46%
2011 โ‚น0.14 B-3.16%
2010 โ‚น0.15 B-2.7%
2009 โ‚น0.15 B21.42%
2008 โ‚น0.12 B-41.52%
2007 โ‚น0.21 B610.82%
2006 โ‚น30.65 M8.13%
2005 โ‚น28.34 M-7.42%
2004 โ‚น30.62 M-80.94%
2003 โ‚น0.16 B-1.82%
2002 โ‚น0.16 B-25.56%
2001 โ‚น0.21 B963.91%
2000 โ‚น20.65 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
โ‚น5.771 T 60,028.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.805 T 39,545.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น8.279 T 86,158.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.23 B-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 44,863.45%๐Ÿ‡บ๐Ÿ‡ธ USA